Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism SAE inhibitors(SUMO-activating enzyme inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC25H28ClN5O5S2 |
InChIKeyLXRZVMYMQHNYJB-UNXOBOICSA-N |
CAS Registry1858276-04-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Phase 2 | ES | 01 Oct 2018 | |
Solid tumor | Phase 2 | UA | 01 Oct 2018 | |
Solid tumor | Phase 2 | US | 01 Oct 2018 | |
Solid tumor | Phase 2 | BE | 01 Oct 2018 | |
Solid tumor | Phase 2 | BE | 01 Oct 2018 | |
Solid tumor | Phase 2 | US | 01 Oct 2018 | |
Solid tumor | Phase 2 | PL | 01 Oct 2018 | |
Solid tumor | Phase 2 | UA | 01 Oct 2018 | |
Solid tumor | Phase 2 | PL | 01 Oct 2018 | |
Solid tumor | Phase 2 | RO | 01 Oct 2018 |
NCT04381650 (ASCO2022) Manual | Phase 1 | 43 | (jahmtsvoqo) = kriwjmoxad vvjaajpfyv (bkcxyrugik ) View more | Positive | 02 Jun 2022 |